Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA

(2020) Feng Wang et al.   Endocrine Practice

New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study

(2020) Lu Lu et al.   EPILEPSIA

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Stroke in patients with SARS-CoV-2 infection: case series

(2020) Mauro Morassi et al.   JOURNAL OF NEUROLOGY

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

(2020) Thomas J. Oxley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Focal status epilepticus as unique clinical feature of COVID-19: A case report

(2020) Catello Vollono et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis Optica spectrum disorder.

(2020) Marina Creed et al.   Multiple Sclerosis and Related Disorders

Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement

(2020) Scott R. Beach et al.   GENERAL HOSPITAL PSYCHIATRY

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

(2020) Céline Louapre et al.   JAMA Neurology

Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment

(2020) Konrad Rejdak et al.   Multiple Sclerosis and Related Disorders

Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab

(2020) Kulachanya Suwanwongse et al.   Multiple Sclerosis and Related Disorders

Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?

(2020) Emin Gemcioglu et al.   Multiple Sclerosis and Related Disorders

Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2017) Valery L Feigin et al.   LANCET NEUROLOGY

The frequency and precipitating factors for breakthrough seizures among patients with epilepsy in Uganda

(2013) Martin Kaddumukasa et al.   BMC Neurology

Clinical Characteristics of Exacerbations in Parkinson Disease

(2012) Karen S. Zheng et al.   NEUROLOGIST

Systemic inflammation and delirium: important co-factors in the progression of dementia

(2011) Colm Cunningham   BIOCHEMICAL SOCIETY TRANSACTIONS

Distribution of Seizure Precipitants Among Epilepsy Syndromes

(2010)   EPILEPSIA